Vascular endothelial cells evade apoptosis triggered by human leukocyte antigen-DR ligation mediated by allospecific antibodies

Transplantation

Volumn 78, Issue 12, 2004, Pages 1729-1739

  Le Bas Bernardet, Stéphanie ^a   Coupel, Stéphanie ^a   Chauveau, Annabelle ^a   Soulillou, Jean Paul ^a   Charreau, Béatrice ^a,b  

^a HÔTEL DIEU   (France)

^b INSERM   (France)

Author keywords

Alloantibodies; Apoptosis; Endothelial cells; HLA DR; Kidney; Transplantation

Indexed keywords

ALLOANTIBODY; GAMMA INTERFERON; HLA ANTIBODY; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; LIPOCORTIN 5;

ANTIGEN BINDING; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DENDRITIC CELL; DNA DETERMINATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; APOPTOSIS; ARTERIES; B-LYMPHOCYTES; CELLS, CULTURED; ENDOTHELIAL CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; ISOANTIBODIES; SIGNAL TRANSDUCTION;

EID: 11144340368     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000147339.31581.99     Document Type: Article

References (35)

1. Scornik JC, LeFor WM, Cicciarelli JC, et al. Hyperacute and acute kidney graft rejection due to antibodies against B cells. Transplantation 1992; 54(1): 61.
2. Itescu S, Tung TC, Burke EM, et al. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation 1998; 98(8): 786.
3. Le Bas-Bernardet S, Hourmant M, Valentin N, et al. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation. Transplantation 2003; 75(4): 477.
4. Susal C, Opelz G. Kidney graft failure and presensitization against HLA class I and class II antigens. Transplantation 2002; 73(8): 1269.
5. McKenna RM, Takemoto SK, Terasaki PI. Anti-HLA antibodies after solid organ transplantation. Transplantation 2000; 69(3): 319.
6. Lee PC, Terasaki PI, Takemoto SK, et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002; 74(8): 1192.
7. Palmer SM, Davis RD, Hadjiliadis D, et al. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. Transplantation 2002; 74(6): 799.
8. Worthington JE, Martin S, Al-Husseini DM, et al. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplantation 2003; 75(7): 1034.
9. Fuller A, Profaizer T, Roberts L, et al. Repeat donor HLA-DR mismatches in renal transplantation: is the increased failure rate caused by noncytotoxic HLA-DR alloantibodies? Transplantation 1999; 68(4): 589.
10. Bian H, Harris PE, Reed EF. Ligation of HLA class I molecules on smooth muscle cells with anti-HLA antibodies induces tyrosine phosphorylation, fibroblast growth factor receptor expression and cell proliferation. Int Immunol 1998; 10(9): 1315.
11. Bian H, Harris PE, Mulder A, et al. Anti-HLA antibody ligation to HLA class I molecules expressed by endothelial cells stimulates tyrosine phosphorylation, inositol phosphate generation, and proliferation. Hum Immunol 1997; 53(1): 90.
12. Drenou B, Blancheteau V, Burgess DH, et al. A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes. J Immunol 1999; 163(8): 4115.
13. Bertho N, Drenou B, Laupeze B, et al. HLA-DR-mediated apoptosis susceptibility discriminates differentiation stages of dendritic/monocytic APC. J Immunol 2000; 164(5): 2379.
14. Pober JS, Collins T, Gimbrone MA Jr, et al. Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. Transplantation 1986; 41(2): 141.
15. Markus BH, Colson YL, Fung JJ, et al. HLA antigen expression on cultured human arterial endothelial cells. Tissue Antigens 1988; 32(5): 241.
16. Pober JS, Orosz CG, Rose ML, et al. Can graft endothelial cells initiate a host anti-graft immune response? Transplantation 1996; 61(3): 343.
17. Pohlman TH, Harlan JM. Human endothelial cell response to lipopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis. Cell Immunol 1989; 119(1): 41.
18. Al-Daccak R, Mooney N, Charron D. MHC class II signaling in antigen-presenting cells. Curr Opin Immunol 2004; 16(1): 108.
19. Savage CO, Hughes CC, McIntyre BW, et al. Human CD4+ T cells proliferate to HLA-DR+ allogeneic vascular endothelium. Identification of accessory interactions. Transplantation 1993; 56(1): 128.
20. Karsan A, Yee E, Harlan JM. Endothelial cell death induced by tumor necrosis factor-alpha is inhibited by the Bcl-2 family member, A1. J Biol Chem 1996; 271(44): 27201.
21. Ferran C, Stroka DM, Badrichani AZ, et al. A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood 1998; 91(7): 2249.
22. Soares MP, Usheva A, Brouard S, et al. Modulation of endothelial cell apoptosis by heme oxygenase-1-derived carbon monoxide. Antioxid Redox Signal 2002; 4(2): 321.
23. Richardson BC, Lalwani ND, Johnson KJ, et al. Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur J Immunol 1994; 24(11): 2640.
24. Rich T, Lawler SE, Lord JM, et al. HLA class II-induced translocation of PKC alpha and PKC beta II isoforms is abrogated following truncation of DR beta cytoplasmic domains. J Immunol 1997; 159(8): 3792.
25. Bertho N, Blancheteau VM, Setterblad N, et al. MHC class II-mediated apoptosis of mature dendritic cells proceeds by activation of the protein kinase C-delta isoenzyme. Int Immunol 2002; 14(8): 935.
26. Guo W, Castaigne JG, Mooney N, et al. Signaling through HLA-DR induces PKC beta-dependent B cell death outside rafts. Eur J Immunol 2003; 33(4): 928.
27. Parekh DB, Ziegler W, Parker PJ. Multiple pathways control protein kinase C phosphorylation. EMBO J 2000; 19(4): 496.
28. Hansra G, Garcia-Paramio P, Prevostel C, et al. Multisite dephosphorylation and desensitization of conventional protein kinase C isotypes. Biochem J 1999; 342(Pt 2): 337.
29. Newton AC. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J 2003; 370(Pt 2): 361.
30. Ruvolo PP, Deng X, Carr BK, et al. A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem 1998; 273(39): 25436.
31. Gliki G, Wheeler-Jones C, Zachary I. Vascular endothelial growth factor induces protein kinase C (PKC)-dependent Akt/PKB activation and phosphatidylinositol 3′-kinase-mediates PKC delta phosphorylation: role of PKC in angiogenesis. Cell Biol Int 2002; 26(9): 751.
32. Madge LA, Pober JS. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells. J Biol Chem 2000; 275(20): 15458.
33. Nath N, Bian H, Reed EF, et al. HLA class I-mediated induction of cell proliferation involves cyclin E- mediated inactivation of Rb function and induction of E2F activity. J Immunol 1999; 162(9): 5351.
34. Le Bas-Bernardet S, Hourmant M, Coupel S, et al. Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis. Am J Transplant 2003; 3(2): 167.
35. Matsuoka T, Tabata H, Matsushita S. Monocytes are differentially activated through HLA-DR, -DQ, and -DP molecules via mitogen-activated protein kinases. J Immunol 2001; 166(4): 2202.